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Abstract. Data on the burden and incidence of endemic Burkitt lymphoma (eBL) across Mozambique are scarce.
We retrospectively retrieved information on eBL cases from reports of the three main hospitals of Mozambique:
Maputo Central Hospital (MCH), Beira Central Hospital (BCH), and Nampula Central Hospital (NCH) between 2004
and 2014. For 2015, we prospectively collected information of new eBL cases attending these hospitals. A total of
512 eBL cases were reported between 2004 and 2015: 153 eBL cases were reported in MCH, 195 in BCH, and 164 in
NCH. Mean age of cases was 6.9 years (standard deviation = 2.8); 63% (319/504) of cases were males. For 2015, the
estimated incidence rate of eBL was 2.0, 1.7, and 3.9 per 106 person-year at risk in MCH, BCH, and NCH, respectively.
Incidence was higher in NCH (northern Mozambique), where intensity of malaria transmission is higher. Data presented
show that eBL is a common pediatric malignancy in Mozambique, as observed in neighboring countries.
Endemic Burkitt lymphoma (eBL) is a B-cell non-Hodgkin
lymphoma genetically characterized by a chromosomal trans-
location t(8,14) that results in deregulation of the c-MYC
oncogene. eBL is the main pediatric cancer in equatorial Africa
accounting for about 50% of childhood cancers, and 90% of
lymphomas. In high-income settings, BL is cured in more than
90% of cases. However, in limited-resource settings, this
percentage is much lower, given poor access to adequate and
complete treatment, late presentation, or treatment-related
mortality. eBL is generally found in areas of sub-Saharan
Africa and Papua New Guinea where Plasmodium falciparum
transmission is holoendemic (reviewed in Molyneux and
others1). Epstein–Barr virus is a necessary agent for eBL
pathogenesis.2 The ecological association between eBL and
P. falciparum was shown in the 1970s,1 but there is still limited
evidence from studies examining this association at an individual
level.3–8 In 2012, the International Agency for Research on
Cancer classified P. falciparum infection in holoendemic areas
as “probably carcinogenic to humans.”9 A better description of
eBL epidemiology is needed to enhance current understanding
of the etiology of the disease. Also, baseline descriptive
epidemiological data are needed to evaluate changes in
incidence rates within and between countries especially with
the implementation of malaria control programs.10
Mozambique stretches from about 2,500 km along the
Indian Ocean in southern Africa, and is part of the “eBL belt.”
Malaria is endemic in Mozambique all year long, although
transmission intensity is higher during the rainy season
(November–April) and varies within the country.11 Data on
eBL in Mozambique are scarce. A recent publication reports
data on pediatric cancer from years 1999–2000 (data from
Maputo city) and 2009–2010 (data from the cities of Maputo
and Beira).12 Between 1999 and 2000, eBL was the most
common pediatric cancer in Maputo, representing 25% of all
pediatric cancers. Between 2009 and 2010, eBL was the third
most common cancer in Maputo (12% of all pediatric cancers)
given the increase of other cancer types (i.e., renal tumors
and Kaposi sarcoma), but the number of eBL cases was
higher than in the preceding period. In Beira city, between
2009 and 2010, eBL accounted for 6% of all pediatric cancers.
The burden of eBL in other parts of the country is unknown.
However, the high levels of malaria transmission as well as
the high eBL burden in neighboring countries such as Malawi
and Zambia13,14 suggest that eBL may represent a major
cause of pediatric cancer. The current report provides for the
first time a description of eBL epidemiology across different
regions of Mozambique.
We reviewed the records of the departments of pathology
of Maputo Central Hospital (MCH), Beira Central Hospital
(BCH), and Nampula Central Hospital (NCH) from January 1,
2004, to December 31, 2014, and recorded information on
age, sex, clinical presentation, and diagnostic methods used
for each case of eBL under 15 years of age. During 2015, we
prospectively collected information from all new eBL cases
under 15 years of age diagnosed in these hospitals, including
information on the lifelong residential history of the children.
MCH is the referral hospital for the southern region (prov-
inces of Maputo, Gaza, and Inhambane), BCH is the referral
hospital for the central region (provinces of Sofala, Manica,
Tete, Zambezia), and NCH for the northern region (provinces
of Nampula, Niassa, and Cabo Delgado). These hospitals
include the only three pathology departments of the country.
We described eBL cases recorded between 2004 and 2015.
We calculated overall incidence rates of eBL for years 2010–
2014. We did not include previous years as estimation of
population was not available before 2007, and we had incom-
plete information of number of eBL cases from Nampula for
the years 2007–2009. For 2015, we calculated overall incidence
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rate and incidence rates of eBL for 5-year age groups and sex
by province of birth (cases with unknown province of birth
were excluded for incidence calculation). To calculate inci-
dence, we used the population estimates from the official pro-
jections of the National Institute of Statistics of Mozambique,
which are based on data from the censuses conducted in 1997
and 2007.15 For 2015, we also mapped the origin of eBL cases
(considering province at onset of eBL) to check the geograph-
ical distribution of the disease and the real coverage of the
three hospitals. Places of residence at onset of eBL were
mapped and overlapped with malaria incidence in Mozambique
according to data from the Malaria Atlas Project16 using
ArcGIS Desktop (ESRI, Redlands, CA, 2016). Data manage-
ment and analysis were done using STATA 12.1 (StataCorp,
College Station, TX). Ethical approval was obtained from the
Manhiça Health Research Center Institutional Bioethics Com-
mittee (CIBS-CISM, Manhiça, Mozambique) and from the
ethical committee for clinical research from Hospital Clínic/
Universitat de Barcelona (CEIC, Barcelona, Spain).
Overall, 512 eBL cases were recorded between 2004 and
2015 in any of the three pathology departments of Mozambique
(Table 1). There were 153 eBL cases in MCH, 195 in BCH, and
164 in NCH. The majority of cases were males (63%, 319/504;
sex unknown for eight cases). Median age at eBL diagnosis
was 6.9 years (standard deviation: 2.8; age unknown for one
case). Facial involvement was the most common clinical pre-
sentation (86% [398/465]), followed by abdominal involvement
(9% [43/465]) and other presentations (5% [24/465]), among
cases with information on clinical presentation. For most of
the eBL cases, diagnosis was based on fine-needle aspiration
cytology (82% [404/494]). Histology (using hematoxylin–eosin
stain) was conducted in 18% (88/494) of cases with informa-
tion on diagnosis method. Diagnosis was confirmed by two
pathologists. In two cases (0.4% [2/494]), diagnosis was based
exclusively on clinical presentation. The overall estimated inci-
dence rates of eBL in Mozambique for the years 2010, 2011,
2012, 2013, 2014, and 2015 were 2.6, 2.2, 2.7, 2.7, 2.5, and 3.0
per 106 person-year at risk (pyar), respectively. The 6-year
average annual incidence was 2.6 per 106 pyar. Data from 2015
showed that estimated incidence of eBL varied in the three
regions of the country, being 2.0, 1.7, and 3.9 per 106 pyar in
the southern region, in the central region, and the northern
region, respectively. In all regions, eBL incidence was higher
among males than among females, and higher among the age
range between 5 and 9 years than among other ages. Details on
estimated incidence by province are presented in Table 2. The
geographical distribution of these cases is presented in Figure 1.
In this work, we provided a description of the epidemiology
of eBL across Mozambique during 12 years, from where infor-
mation on eBL was limited.12 Distribution by sex, age, and
anatomical location of eBL in Mozambique are in line with
the published literature.3,4,17,18 Incidence of eBL between
2010 and 2014 ranged between 2.2 in 2011 to 3.0 per 106 pyar
in 2015. The higher incidence observed in 2015 can be poten-
tially explained by the active detection of cases. eBL incidence
reported here is similar to crude incidence estimated in Kenya
between 1999 and 2004 (i.e., 2.15 per 106 pyar).18 Reported
crude incidence rate in Uganda is lower (1.8 per 106 pyar),19
whereas in Tanzania is higher (i.e., 4.2 per 106 pyar).17 Infor-
mation on population-based incidence of eBL in other African
countries is scarce but several reports indicate that eBL is
the most common childhood cancer in several African set-
tings.14 For 2015, we showed for the first time the estimated
TABLE 1
Number of endemic Burkitt lymphoma cases per year according to
pathological records of Maputo Central Hospital, Beira Central










2004 14 (39) 18 (50) 4 (11) 36 (100)
2005 17 (27) 27 (42) 20 (31) 64 (100)
2006 30 (38) 33 (42) 15 (19) 78 (100)
2007 13 (42) 17 (55) 1 (3)* 31 (100)
2008 11 (41) 14 (52) 2 (7)* 27 (100)
2009 12 (36) 13 (39) 8 (24)* 33 (100)
2010 11 (32) 9 (26) 14 (41) 34 (100)
2011 13 (35) 9 (24) 15 (41) 37 (100)
2012 7 (17) 18 (43) 17 (60) 42 (100)
2013 10 (20) 10 (20) 31 (61) 51 (100)
2014 11 (24) 16 (36) 18 (40) 45 (100)
2015 4 (12) 11 (32) 19 (40) 34 (100)
Total 153 (30) 195 (38) 164 (32) 512 (100)
*Registers were incomplete for these years.
TABLE 2
Incidence rate of endemic Burkitt lymphoma per 106 person-year at risk by province of birth and by age group and sex for the year 2015
Region of birth Province of birth†
Age group*
1–4 5–9 10–14 All
All Male Female All Male Female All Male Female All Male Female
South Maputo 0.0 0.0 0.0 0.0 0.0 0.0 4.7 9.6 0.0 1.5 3.1 0.0
Gaza 0.0 0.0 0.0 4.7 9.4 0.0 0.0 0.0 0.0 1.6 3.1 0.0
Inhambane 0.0 10.5 0.0 4.4 0.0 8.6 0.0 0.0 0.0 1.5 3.0 2.9
Central Sofala 0.0 0.0 0.0 3.2 6.5 0.0 0.0 0.0 0.0 1.1 2.1 0.0
Manica 3.5 0.0 7.0 6.6 6.6 6.5 0.0 0.0 0.0 3.2 2.1 4.2
Tete‡ – – – – – – – – – – – –
Zambezia§ 2.9 2.9 2.9 2.7 0.0 0.0 1.6 3.2 0.0 2.2 1.8 0.9
North Nampula¶ 7.5 9.0 3.0 8.3 8.3 8.2 3.2 3.2 3.2 5.9 6.4 4.6
Niassa 0.0 0.0 0.0 4.0 0.0 8.0 0.0 0.0 0.0 1.3 0.0 2.6
Cabo Delgado 0.0 0.0 0.0 3.6 7.2 0.0 0.0 0.0 0.0 1.2 2.4 0.0
*All eBL cases were ≥ 1 year.
†Five eBL cases had no information on province or region of birth and therefore could not be included in incidences calculated by province. They were included in the overall incidence
calculation reported in the text.
‡No eBL cases were diagnosed from Tete.
§Two eBL cases had no information on sex and were not included in incidence calculation stratified by sex, but they were included in the overall incidence calculation for Zambezia.
¶One eBL case from Nampula had no information on age and was not included in incidence calculation; one eBL case had no information on sex and was not included in incidence calculation
stratified by sex, but it was included in the overall incidence calculation for Nampula.
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incidence rates of eBL for different regions of the country.
Incidence rate of eBL was higher in NCH, in the northern
region of Mozambique, where the intensity of malaria trans-
mission is higher.16
There are important limitations that might have under-
estimated the incidence of eBL. First, Mozambique has large
borders with Malawi, Zambia, and Zimbabwe, which might
prompt patients with residences at long distances from
national referral hospitals to go to closer health facilities in
foreign countries. For example, there were no cases recorded
during 2015 from Tete, the province that borders with
Malawi, Zambia, and Zimbabwe, that is more distant to the
central region referral hospital (i.e., BCH). In a study
conducted in Malawi in 2005–2006, 31 of 664 children
recruited with cancer, including 20 eBL cases, were from
Mozambique.4 Second, attendance to hospital in Mozambique
is low,20 and therefore we can assume that not all eBL cases
reach one of the three referral hospitals. This might be spe-
cially the case in rural and poorest areas, where eBL inci-
dence is expected to be higher. On the other hand, diagnosis
of eBL in Mozambique was mainly based on cytology, with
no further tests on immunocytochemistry or genetics. This
might have led to misclassification of some eBL cases.
Despite these limitations, the data presented here show
FIGURE 1. Place of residence of each endemic Burkitt lymphoma (eBL) case at onset of eBL during 2015 and malaria incidence in Mozambique
based on the Malaria Atlas Project (http://www.map.ox.ac.uk/).
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that eBL is a common pediatric malignancy in Mozambique,
as observed in neighboring countries. Given the climatic and
geographic diversity and the variation in levels of malaria
transmission in Mozambique, studies on eBL involving dif-
ferent regions of the country would help in identifying addi-
tional cases, risk factors, and eventually implementing
measures for the control of this disease.
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